Dimethyl 4-Nitrophthalate (CAS: 610-22-0) plays a significant role in the pharmaceutical industry as a versatile intermediate. Its molecular structure, C10H9NO6, with a molecular weight of 239.18, and its characteristic nitro group, make it a valuable building block for synthesizing a wide range of active pharmaceutical ingredients (APIs) and other complex organic molecules.

The compound's utility in pharmaceutical synthesis stems from the reactivity of its nitro group and ester functionalities. These allow for various chemical transformations, including reduction to amines, which are common functional groups in many drugs. Pharmaceutical researchers and formulation scientists often seek this intermediate to develop new therapeutic agents or to optimize existing synthesis routes. For those looking to buy Dimethyl 4-Nitrophthalate, understanding its purity and source is critical.

Reliable suppliers, particularly those operating as manufacturers in China, are crucial for the pharmaceutical sector. They ensure that Dimethyl 4-Nitrophthalate is produced to high purity standards, typically above 98.0%, and maintained with consistent quality. This consistency is vital for reproducible results in drug synthesis and for meeting regulatory requirements. Procurement of this chemical intermediate necessitates careful vetting of suppliers to guarantee not only quality but also a stable supply chain and competitive pricing.

When engaging with manufacturers for Dimethyl 4-Nitrophthalate, pharmaceutical companies often inquire about lead times, packaging options (e.g., 25kg drums), and storage recommendations. The ability to obtain quotes and samples easily facilitates the decision-making process. By partnering with reputable chemical manufacturers, pharmaceutical firms can confidently procure the essential raw materials needed for drug discovery and production, thereby accelerating the development of life-saving medications.